CGRP receptor antagonist

This page covers all CGRP receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Calcitonin gene-related peptide (CGRP) receptor, CGRP receptors, CGRP receptor.

Targets

Calcitonin gene-related peptide (CGRP) receptor · CGRP receptors · CGRP receptor · CGRP receptor (calcitonin gene-related peptide receptor)

Marketed (3)

• Nurtec Odt · Pfizer · Neuroscience · 1424
  Rimegepant is a calcitonin gene-related peptide receptor antagonist.
• Zavzpret · Pfizer · Neuroscience
  Zavegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist for acute migraine treatment.
• rimegepant 75 mg ODT · Pfizer · Neuroscience

Phase 3 pipeline (4)

• Placebo to telcagepant tablets · Merck Sharp & Dohme LLC · Neurology
  Telcagepant is a calcitonin gene-related peptide receptor antagonist.
• Placebo to Telcagepant · Merck Sharp & Dohme LLC · Neurology
  Telcagepant is a calcitonin gene-related peptide receptor antagonist.
• Placebo to telcagepant capsules · Merck Sharp & Dohme LLC · Neurology
  Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist that blocks CGRP signaling to prevent migraine attacks.
• Placebo-Matching Atogepant · AbbVie · Neurology
  Atogepant is a calcitonin gene-related peptide (CGRP) receptor antagonist that blocks CGRP signaling to prevent migraine.

Phase 2 pipeline (4)

• Any treatment for cluster headache · Samsung Medical Center · Neurology
  This drug targets the calcitonin gene-related peptide (CGRP) receptor to prevent cluster headache attacks.
• AMG 334 Dose 1 · Amgen · Neurology
  AMG 334 is a fully human monoclonal antibody that targets and inhibits the activity of the calcitonin gene-related peptide (CGRP) receptor.
• BHV-7000 · Biohaven Therapeutics Ltd. · Neurology
  BHV-7000 is a calcitonin gene-related peptide receptor antagonist.
• BHV-2100 · Biohaven Therapeutics Ltd. · Neurology
  BHV-2100 is a calcitonin gene-related peptide receptor antagonist.